Monte Carlo design study for in vivo bone aluminum measurement using a low energy accelerator beam

Applied Radiation and Isotopes

Volumn 53, Issue 4-5, 2000, Pages 657-664

  Pejovic Milic A ^a   Arnold, M L ^a   McNeill, F E ^a   Chettle, D R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Aluminum; Bone; Monte Carlo; Neutron activation analysis

Indexed keywords

ALUMINUM; BONE; COMPUTER SIMULATION; DOSIMETRY; MODERATORS; MONTE CARLO METHODS; NEUTRON SOURCES; PARTICLE ACCELERATORS; PATIENT MONITORING;

BONE ALUMINUM MEASUREMENT; GRAPHITE REFLECTOR; LOW ENERGY ACCELERATOR BEAM; RENAL DYSFUNCTION;

NEUTRON ACTIVATION ANALYSIS;

ALUMINUM; POLYETHYLENE;

BONE TISSUE; CONFERENCE PAPER; FAST NEUTRON RADIATION; GAMMA IRRADIATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MICRODOSIMETRY; NEUTRON ACTIVATION ANALYSIS; NEUTRON RADIATION; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION ENERGY; SYSTEM ANALYSIS;

ALUMINUM; BONE AND BONES; COMPUTER SIMULATION; FACILITY DESIGN AND CONSTRUCTION; FAST NEUTRONS; FILTRATION; HAND; HUMANS; MODELS, ANATOMIC; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NEUTRON ACTIVATION ANALYSIS; PARTICLE ACCELERATORS; PHANTOMS, IMAGING; PROTONS; RADIATION PROTECTION;

EID: 0342626747     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(00)00200-1     Document Type: Article

References (18)

1. Alfrey A.C. Aluminum intoxication. N. Engl. J. Med. 310:1984;1113-1115.
2. Arnold M.L., McNeill F.E., Prestwich W.V., Chettle D.R. Monte Carlo modeling of accelerator based in vivo neutron activation measurements of manganese levels in human brain: system design and detection limit. 4th Topical Meeting on Industrial Radiation and Radioisotope Measurement Applications, Raleigh, NC, USA. 1999.
3. Caswell R.S., Coyne J.J., Randolph M.L. Kerma factors of elements and compounds for neutron energies below 30 MeV. Int. J. Appl. Radiat. Isot. 33:1982;1227-1262.
4. Ellis K.J., Kelleher S., Raciti A., Savory J., Wills M. In vivo monitoring of skeletal aluminum burden in patients with renal failure. J. Radianalyt. Nucl. Chem. Ar. 124:(1):1988;85-95.
5. Green S., Chettle D.R. A feasibility of the in vivo measurement of aluminum in peripheral bone. Phys. Med. Biol. 37:(12):1992;2287-2296.
6. Hubbell, J.H., Seitzer, S.M. 1996. http://physics.nist.gov/PhysRefData/contents.html.
7. Report of the Task Group on Reference Man. vol. 23:1975;Pergamon Press, Oxford.
8. 252Cf source for in vivo neutron activation analysis of aluminum. Phys. Med. Biol. 42:1997;625-636.
9. 7Be>. Atomic Data Nucl. Tables. 15:(1):1975;57-84.
10. Martyn, C.N. et al., 1989 Geographical relation between Alzheimer's disease and aluminum in drinking water, The Lancet, 14 January 59-62.
11. McLachan D.R.C., Kruck T.P., Lukiw W.J., Krishnan S.S. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? Can. Med. Ass. J. 145:(7):1991;793-804.
12. Nuclear Data Tables, part 3, 1960. National Academy of Science, Washington, DC.
13. O'Mahony D., Denton J., Templer J., O'Hara M., Day J.P., Murphy S., et al. Bone aluminum content in Alzheimer's disease. Dementia. 6:1995;69-72.
14. Palerme S., Chettle D.R., Kennett T.J., Prestwich W.V., Webber C.E. Ellis K.J., Eastman J.D. Pilot Study for in vivo Aluminum Measurement. 1993;303-306 Plenum Press, New York.
15. Pejović-Milić A., McNeill F.E., Prestwich W.V., Waker A.J., Chettle D.R. Development of an accelerator based determination of aluminum burden in peripheral bone by neutron activation analysis. Appl. Radiat. Isot. 49:(5/6):1998;717-719.
16. Pejović-Milić A., McNeill F.E., Chettle D.R. The development of an in vivo procedure for routine aluminum monitoring in human bone by neutron activation analysis. COMP & CCPM Conference Proceedings, London, Canada. 1998;222-224.
17. 7Be reaction (thick target) with incident energies from 1.885 to 2.0 MeV. Med. Phys. 25:(7):1998;1222-1224.
18. Yanch J.C., Zhou X.-L., Shefer R.E., Klinkowstein R.E. Accelerator-based epithermal neutron beam design for neutron capture therapy. Med. Phys. 19:(3):1992;709-721.